Brooks Laboratories Limited (BROOKS) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE650L01011
Key metrics
- Market Cap
- ₹178 Cr
- P/E Ratio
- 7.22
- EPS
- 8.35
- Book Value
- 41.64
- P/B Ratio
- 1.45
- ROE
- 20.04%
- ROCE
- 4.17%
- Debt / Equity
- 0.07
- Net Margin
- 28.67%
- Revenue Growth
- 3.85%
- Profit Growth
- 346.65%
- Dividend Yield
- —
- 52W High
- ₹163.90
- 52W Low
- ₹36.30
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Brooks Laboratories Limited
Brooks Laboratories Limited operates as a pharmaceutical manufacturer in India and internationally. It operates in two segments, Manufacturing and Trading. The company offers liquid injection ampoules and vials, dry powder injection vials, lyophilized injections, eye/ear drops, and nasal drops; and B-Lactam and cephalosporin tablets, dry powder syrups, and injections. It is also involved in loan-licensing business relating to pharmaceutical products, ingredients, and intermediaries; and trading in pharmaceutical products, ingredients, and intermediaries. In addition, the company offers oncology products and hormonal injections; and formulations for therapeutic areas comprising antibiotic, pain management, controlled drugs. It exports its products to Afghanistan, Yemen, Kosovo, Bolivia, Guatemala, Turkmenistan, Nigeria, Lebanon, Mauritius, Sudan, Madagascar, the Democratic Republic of Congo, Angola, Mozambique, Latin America, and Africa. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.
- Headquarters
- Mumbai, India
- Employees
- 347
- Promoter Holding
- 55.88%
The full Brooks Laboratories Limited analysis
Create a free account to open the complete BROOKS deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.